Yongin Severance Hospital

Running trials

• Not yet recruiting

  A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or Both

  NCT07931599· Phase 3· Novo Nordisk A/S· Source

• Recruiting

  Continuous Blood Pressure Variability and Small Vessel Disease in Acute Ischemic Stroke

  NCT07903922· Minyoul Baik· Source

• Not yet recruiting

  A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity

  NCT07861100· Phase 3· Novo Nordisk A/S· Source

• Recruiting

  Patient-Specific MRD Liquid Biopsy in Resected NSCLC: Plasma and Bronchial Washing ctDNA

  NCT07921888· Eun Hye Lee· Source

• Recruiting

  Evaluate the Effectiveness and Safety of At-Home Rehabilitation Gait Training Using a Hip-assisted Wearable Robot in Stroke Patients

  NCT07716475· Yonsei University· Source

• Recruiting

  Effectiveness and Safety of Sequential Triple Combination Therapy (Amlodipine/Losartan/Chlorthalidone) in Korean Patients With Hypertension

  NCT07784296· Hanmi Pharmaceutical Company Limited· Source

• Enrolling by invitation

  WEgovy Real World Assessment of Weight Loss in Korea

  NCT07280221· Novo Nordisk A/S· Source

• Recruiting

  A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe

  NCT07083206· Ahn-Gook Pharmaceuticals Co.,Ltd· Source

• Recruiting

  AI-based Prediction of Cardiac Function Using Echocardiography and Body Composition Data (ECHO-FIT Study)

  NCT06811519· Yonsei University· Source

• Not yet recruiting

  Digital CBT-I for Chronic Insomnia

  NCT06695000· WELT corp· Source

• Recruiting

  Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke

  NCT06649240· Seoul National University Hospital· Source

• Recruiting

  Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine

  NCT06603558· AbbVie· Source

• Recruiting

  Comparison of Functional Recovery After Total Knee Arthroplasty Between Low Phase Angle and High Phase Angle Group

  NCT06701474· Yonsei University· Source

• Active, not recruiting

  Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)

  NCT06564142· Phase 3· Alpine Immune Sciences Inc, A Subsidiary of Vertex· Source

• Recruiting

  Effectiveness and Safety of At-home Gait Rehabilitation Using Wearable Exoskeletal Robot

  NCT06543758· Phase 4· Yonsei University· Source

• Recruiting

  Atezolizumab and BEvacizumab With STereotactic Body Radiotherapy for Advanced Hepatocellular Carcinoma

  NCT06595108· Yonsei University· Source

• Recruiting

  Fractional Flow Reserve Versus Angiography for Treatment-Decision and Evaluation of Significant Left MAIN Coronary Artery Disease

  NCT05829889· Seung-Jung Park· Source

• Recruiting

  Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia

  NCT06772168· Phase 3· CMG Pharmaceutical Co. Ltd· Source

• Recruiting

  A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants

  NCT06246123· Eisai Korea Inc.· Source

• Active, not recruiting

  Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE

  NCT05995600· Phase 4· Seoul National University Hospital· Source

• Recruiting

  The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN Trial

  NCT05753839· Yonsei University· Source

• Active, not recruiting

  Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial)

  NCT05910476· Phase 4· Yonsei University· Source

• Active, not recruiting

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

  NCT05702034· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  Korean Registry of Non-Small Cell Lung Cancer Patients with EGFR Mutation

  NCT06247280· Yuhan Corporation· Source

• Active, not recruiting

  Efficacy and Safety of Zotarolimus-eluting Stent Overexpansion With OCT

  NCT05340361· Yonsei University· Source

• Recruiting

  Long-Term Follow-up of Patients With Alcoholic Liver Cirrhosis Treated With Cellgram-LC

  NCT05093881· Pharmicell Co., Ltd.· Source

• Active, not recruiting

  CREATE Trial, Prospective, Observational Study

  NCT05658250· Yonsei University· Source

• Recruiting

  Prediction of Postoperative Outcomes After TKA Using Instrumented Insoles and DNN

  NCT07367789· Yonsei University· Source

• Recruiting

  Identifying Gait Changes From a CSF Tap Test Using a Smart Insole in iNPH

  NCT06722768· Yonsei University· Source

• Recruiting

  Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis

  NCT04689152· Phase 3· Pharmicell Co., Ltd.· Source

• Active, not recruiting

  Prospective Study of MAstectomy With Reconstruction Including Robot Endoscopic Surgery

  NCT04585074· Severance Hospital· Source

• Recruiting

  Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

  NCT04174157· Novartis Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Stroke4 recruiting
• Liver cirrhosis2 recruiting
• Obesity2 recruiting
• Osteoarthritis2 recruiting
• Type 2 diabetes2 recruiting
• Coronary artery disease1 recruiting
• Familial hypercholesterolaemia1 recruiting
• Heart failure1 recruiting
• High blood pressure1 recruiting
• Hydrocephalus1 recruiting
• Insomnia1 recruiting
• Kidney cancer1 recruiting
• Liver and biliary tract cancer1 recruiting
• Lung cancer1 recruiting
• Migraine1 recruiting
• Rheumatoid arthritis1 recruiting
• Spinal muscular atrophy1 recruiting
• Ulcerative colitis1 recruiting

Closed trials

• Completed

  Evaluate the Efficacy and Safety of the Digital Therapeutics Repeech for the Post-Stroke Dysarthria.

  NCT06670014· HAII corp.ltd· Source

• Completed

  Effect of Bra Use During Radiotherapy for Breast Cancer Radiotherapy

  NCT06178861· Yonsei University· Source

• Completed

  Diastolic Hyperemia-Free Ratio in Patients With CAD

  NCT05421169· Yonsei University· Source

• Completed

  Genoss DES in Patients With a High Risk of Ischemic Events (GENTLE Registry)

  NCT05448625· Yonsei University· Source

• Completed

  Feasibility of PCI Using a 7-Fr Thin-Walled Sheath Via the DRA

  NCT05006027· Yonsei University· Source

• Completed

  Safety and Efficacy of the Ultimaster Stent

  NCT05677711· Yonsei University· Source

• Completed

  A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis

  NCT04541810· AbbVie· Source

• Completed

  Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis

  NCT04433442· AbbVie· Source

Conditions

Diseases this institution publishes on or runs trials for.

• ANCA-associated vasculitis7 works · 0 trials
• Multiple system atrophy5 works · 0 trials